Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:917-927
Published online before print August 7, 2007, doi: 10.1161/CIRCULATIONAHA.106.668178
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v116,pe348)
Right arrow All Versions of this Article:
116/8/917    most recent
CIRCULATIONAHA.106.668178v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winter, E.M.
Right arrow Articles by Gittenberger-de Groot, A.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winter, E.M.
Right arrow Articles by Gittenberger-de Groot, A.C.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Acute myocardial infarction

(Circulation. 2007;116:917-927.)
© 2007 American Heart Association, Inc.


Molecular Cardiology

Preservation of Left Ventricular Function and Attenuation of Remodeling After Transplantation of Human Epicardium-Derived Cells Into the Infarcted Mouse Heart

E.M. Winter, MD; R.W. Grauss, MD; B. Hogers, PhD; J. van Tuyn, MSc; R. van der Geest, PhD; H. Lie-Venema, PhD; R. Vicente Steijn, MSc; S. Maas, BSc; M.C. DeRuiter, PhD; A.A.F. deVries, PhD; P. Steendijk, PhD; P.A. Doevendans, MD, PhD; A. van der Laarse, PhD; R.E. Poelmann, PhD; M.J. Schalij, MD, PhD; D.E. Atsma, MD, PhD; A.C. Gittenberger-de Groot, PhD

From the Departments of Anatomy & Embryology (E.M.W., B.H., H.L.-V., R.V.S., S.M., M.C.D., R.E.P., A.C.G.-d.G.), Cardiology (R.W.G., J.v.T., P.S., A.v.d.L., M.J.S., D.E.A.), Molecular Cell Biology (J.v.T., A.A.F.d.V.), and Radiology (R.v.d.G.), Leiden University Medical Center, Leiden, The Netherlands; and Department of Cardiology, University Medical Center Utrecht (P.A.D.), Utrecht, The Netherlands.

Correspondence to Professor Dr A.C. Gittenberger-de Groot, Leiden University Medical Center, Department of Anatomy and Embryology, Einthovenweg 20, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail acgitten{at}lumc.nl

Received October 4, 2006; accepted June 20, 2007.

Background— Proper development of compact myocardium, coronary vessels, and Purkinje fibers depends on the presence of epicardium-derived cells (EPDCs) in embryonic myocardium. We hypothesized that adult human EPDCs might partly reactivate their embryonic program when transplanted into ischemic myocardium and improve cardiac performance after myocardial infarction.

Methods and Results— EPDCs were isolated from human adult atrial tissue. Myocardial infarction was created in immunodeficient mice, followed by intramyocardial injection of 4x105 enhanced green fluorescent protein–labeled EPDCs (2-week survival, n=22; 6-week survival, n=15) or culture medium (n=24 and n=18, respectively). Left ventricular function was assessed with a 9.4T animal MRI unit. Ejection fraction was similar between groups on day 2 but was significantly higher in the EPDC-injected group at 2 weeks (short term), as well as after long-term survival at 6 weeks. End-systolic and end-diastolic volumes were significantly smaller in the EPDC-injected group than in the medium-injected group at all ages evaluated. At 2 weeks, vascularization was significantly increased in the EPDC-treated group, as was wall thickness, a development that might be explained by augmented DNA-damage repair activity in the infarcted area. Immunohistochemical analysis showed massive engraftment of injected EPDCs at 2 weeks, with expression of {alpha}-smooth muscle actin, von Willebrand factor, sarcoplasmic reticulum Ca2+-ATPase, and voltage-gated sodium channel ({alpha}-subunit; SCN5a). EPDCs were negative for cardiomyocyte markers. At 6-weeks survival, wall thickness was still increased, but only a few EPDCs could be detected.

Conclusions— After transplantation into ischemic myocardium, adult human EPDCs preserve cardiac function and attenuate ventricular remodeling. Autologous human EPDCs are promising candidates for clinical application in infarcted hearts.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. M. Pedrotty, R. Y. Klinger, N. Badie, S. Hinds, A. Kardashian, and N. Bursac
Structural coupling of cardiomyocytes and noncardiomyocytes: quantitative comparisons using a novel micropatterned cell pair assay
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H390 - H400.
[Abstract] [Full Text] [PDF]